Domènech-Montoliu, S.; Puig-Barberà , J.; Badenes-Marques, G.; Gil-Fortuño, M.; Orrico-Sánchez, A.; Pac-Sa, M.R.; Perez-Olaso, O.; Sala-Trull, D.; Sánchez-Urbano, M.; Arnedo-Pena, A.
Long COVID Prevalence and the Impact of the Third SARS-CoV-2 Vaccine Dose: A Cross-Sectional Analysis from the Third Follow-Up of the Borriana Cohort, Valencia, Spain (2020–2022). Vaccines 2023, 11, 1590.
https://doi.org/10.3390/vaccines11101590
AMA Style
Domènech-Montoliu S, Puig-Barberà J, Badenes-Marques G, Gil-Fortuño M, Orrico-Sánchez A, Pac-Sa MR, Perez-Olaso O, Sala-Trull D, Sánchez-Urbano M, Arnedo-Pena A.
Long COVID Prevalence and the Impact of the Third SARS-CoV-2 Vaccine Dose: A Cross-Sectional Analysis from the Third Follow-Up of the Borriana Cohort, Valencia, Spain (2020–2022). Vaccines. 2023; 11(10):1590.
https://doi.org/10.3390/vaccines11101590
Chicago/Turabian Style
Domènech-Montoliu, Salvador, Joan Puig-Barberà , Gema Badenes-Marques, MarÃa Gil-Fortuño, Alejandro Orrico-Sánchez, MarÃa Rosario Pac-Sa, Oscar Perez-Olaso, Diego Sala-Trull, Manuel Sánchez-Urbano, and Alberto Arnedo-Pena.
2023. "Long COVID Prevalence and the Impact of the Third SARS-CoV-2 Vaccine Dose: A Cross-Sectional Analysis from the Third Follow-Up of the Borriana Cohort, Valencia, Spain (2020–2022)" Vaccines 11, no. 10: 1590.
https://doi.org/10.3390/vaccines11101590
APA Style
Domènech-Montoliu, S., Puig-Barberà , J., Badenes-Marques, G., Gil-Fortuño, M., Orrico-Sánchez, A., Pac-Sa, M. R., Perez-Olaso, O., Sala-Trull, D., Sánchez-Urbano, M., & Arnedo-Pena, A.
(2023). Long COVID Prevalence and the Impact of the Third SARS-CoV-2 Vaccine Dose: A Cross-Sectional Analysis from the Third Follow-Up of the Borriana Cohort, Valencia, Spain (2020–2022). Vaccines, 11(10), 1590.
https://doi.org/10.3390/vaccines11101590